Association between trisomy 8 and the immunophenotype of blast cells from acute leukemias secondary to a myelodysplastic syndrome or chronic myeloproliferative disorders

Annals of Hematology

Volumn 74, Issue 5, 1997, Pages 209-214

  Garcia Isidoro, M ^a   Tabernero, M D ^a   Najera, M L ^a   Lopez Berges, M C ^a   Martinez, A ^a   Duran A ^a   Garcia, J L ^a   Hernandez, J M ^a   Garcia Marcos, M A ^a   San Miguel, J F ^a   Orfao, A ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Cell cycle; FISH; Immunophenotype; MDS; MPD; Secondary leukemia

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ACUTE LEUKEMIA; ARTICLE; BLAST CELL; CELL CYCLE; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; TRISOMY 8;

ACUTE DISEASE; AGED; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; TRISOMY;

EID: 0030905988     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050286     Document Type: Article

References (47)

1. Andrieu V, Radford-Weiss Y, Troussard X, Chane C, Valensi F, Guesnu M, Haddad E, Viguier F, Dreyfus F, Varet B, Flandrin G, MacIntyre E (1996) Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Haematol 92:855-865
2. Ankathil JR, Stephen DM, Vasudevan P, Kusumakumary G, Raiasekharam P, Krishnan N (1992) Prognostic significance of karyotype analysis in children with acute lymphoblastic leukaemia. Hematol Oncol 10:339-344
3. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (FAB COOPERATIVE GROUP) (1982) Proposals for the classification of myelodysplastic syndromes. Br J Haematol 51:189-199
4. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick H, Sultan C (FAB group) (1985) Proposed revised criteria for the classification of AML. Ann Intern Med 103:626-629
5. Berlin NI (1975) Diagnosis and classification of the policy-themias. Semin Haematol 12:339-629
6. Biondi A, Luciano A, Bassan R, Mininni D, Specchia G, Lanzi E, Castagna S, Cantu-Rajnoldi A, Liso V, Masera G, Barbui T, Rambaldi A (1995) CD2 expression in acute promyelocytic leukaemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. Leukemia 9:1461-1466
7. Brizard F, Brizard A, Guilhot F, Tnzar J, Berger R (1994) Detection of monosomy 7 and trisomy 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridisation. Comparison with acute non-lymphocytic leukaemias. Leukemia 8:1005-1011
8. Carbonell F, Benitez J, Prieto F, Badia L, Sanchez-Fayos J (1982) Chromosome banding patterns in patients with chronic myelocytic leukemia. Cancer Genet Cytogenet 5:287-297
9. Cervantes F, Rozman M, Rosell J, Urbano-Ispizua A, Montserrat E, Rozman C (1990) A study of prognostic factors in blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia. Br J Haematol 76:27-32
10. Claxton DF, Reading CL, Nagarajan L, Tsujimoto Y, Andersson BS, Estey E, Cork A, Huh YO, Trujillo J, Deisseroth AB (1992) Correlation of CD2 expression with PML gene breakpoint in patients with acute promyelocytic leukemia. Blood 80:582-585
11. Dixon WJ (1983) BMDP statistical software. University of California Press, Berkeley
12. Fagioli F, Cuneo A, Bardia A (1995) Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. A multiparameter analysis combining conventional cytogenetics, DNA in situ hybridisation, and bone marrow culture studies. Cancer Genet Cytogenet 82:116-122
13. First MIC Cooperative Study Group (1985) Morphologic, immunologic and cytogenetic (MIC) working classification of acute lymphoblastic leukaemias. Cancer Genet Cytogenet 23:189-197
14. Fugazza G, Bruzzone R, Dejana AM, Gobbi M, Ghio R, Patrone F, Rattenni S, Sessarego M (1995) Cytogenetic clonality in chronic myelomonocytic leukaemia studied with fluorescence in situ hybridisation. Leukemia 9:109-114
15. Gonzalez M, San Miguel JF, Anta JP, Ojeda E, Lopez-Borrasca A (1987) Cell lineage switches in blast crisis of Ph-positive chronic granulocytic leukaemia. Br Hematol 72:249-51
16. Haase D, Fonatsch C, Freund M (1995) Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol 70:171-187
17. Han K, Lee W, Harris CP, Kim W, Shim S, Meisner LF (1995) Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridisation (FISH). Leukemia 8:81-86
18. Jenkins RB, Le Beau MM, Kaker WJ, Borell TJ, Stalboerger PG, Davis EM, Penland L, Fernald A, Espinosa R, Schaid DJ, Noel P, Dewald GW (1992) Fluorescence in situ hybridisation: a sensitive method for trisomy 8 detection in bone marrow specimens. Blood 79:3307-3315
19. Kantarjian HM, Keating MJ, Talpaz M, Walters SR, Smith TL, Cork A, McCredie KB, Freireich EJ (1987) Chronic myelogenous leukaemia in blast crisis. Analysis of 242 patients. Am J Med 83:445-454
20. Keating MJ, Smith TL, Kantarjian H, Cork A (1988) Cytogenetic pattern in acute myelogenous leukaemia: a major reproducible determinant of outcome. Leukemia 2:403-412
21. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N (1992) Phenotypical characteristics of acute myelocytic leukaemia associated with the t(8;21) (q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80:470-477
22. Macedo A, Orfao A, González M, Vidriales MB, Lopez-Berges MC, Martinez A, San Miguel JF (1995) Immunological detection of blast cell subpopulations in acute myeloblastic leukaemia at diagnosis: implications for minimal residual disease studies. Leukemia 9:993-998
23. Mifflin TE (1989) Use applications of nucleic acid probes in clinical laboratory. Clin Chem 35:1819-1825
24. Mitelman F (1988) Catalogue of chromosome aberrations in cancer. 3rd edn. Alan R. Liss, New York
25. Murphy S, Lland H, Rosenthal D, Lazslo J (1986) Essential thrombocythemia: an interim report of the Polycythemia Vera Study Group. Semin Oncol 23:177-182
26. Neal BG, Jhanwar SC, Chaganti RSK, Hyward WS (1982) Two human c-oncogenes are located on the long arm of chromosome 8. Proc Nat Acad Sci USA 79:7842-7846
27. Nguyen PL, Arthur DC, Litz CE, Brunning RD (1994) Fluorescence in situ hybridisation (FISH) detection of trisomy 8 in myeloid cells of chronic myeloid leukaemia (CML): a study of archival blood and bone marrow smears. Leukemia 8:1654-1662
28. Orfao A, González M, Ciudad J. López-Berges MC, López A, Vidriales B, Macedo A, San Miguel JF (1993) Cell cycle and DNA aneuploidy: biological bases and terminology. In: Sampedro A, Orfao E (eds) DNA cytometric analysis. Universidad de Oviedo; pp 13-24
29. Porto B, Mota A, Coutinho J, Justicia B, Melheiro MI (1992) Estudios citogenéticos en enfermedades hematológicas. Sangre 38:103-115
30. Porwit-MacDonald A, Janossy G, Ivory K, Swirsky D, Peters R, Wheatley K, Walker H, Turker A, Goldstone AH, Burnett A (1996) Leukaemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukaemia M2 with t(8;21). Blood 87:1162-1169
31. Raza A, Muddle S, Iftikhar A, Gregory S, Marcus B, Khan Z, Alvi S, Shelly V, Dameron S, Wright V (1995) Simultaneous assessment of cell kinelics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hemalol 48:143-154
32. San Miguel JF, Hernández JM, González Sarmiento R, Gonzalez M, Sanchez I, Orfao A, Cañizo MC. Lopez-Borrasca A (1991) Acute leukaemia after primary myelodysplaslic syndrome: immunophenotypic, genotypic and clinical characteristics. Blood 78:768-774
33. Sandberg AA (1990) The chromosome in human cancer and leukaemia, 2nd edn. Elsevier, New York
34. Schiffer C, Lee EJ, Tomiyasu T, Wiernick PH, Testi JR (1989) Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukaemia. Blood 73:263-270
35. Second MIC Cooperative Study Group (1986) Morphologic, immunologic and cytogenetic (MIC) working classification of acute myeloid leukaemias. Cancer Genet Cytogenet 30:1-15
36. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH (1994) Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukaemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia 8:823-826
37. Shackney SE, Singh SG, Yakulis R, Smith CA, Pollice AA, Petruolo S, Waggoner A, Hartsock RJ (1995) Aneuploidy in breast cancer: a fluorescence in situ hybridisation study. Cytometry 22:282-291
38. Stasi R, Poeta GD, Venditti A, Masi M, Stipa E, Dentamaro T, Cox C, Dallapiccola B, Papa G (1994) Analysis of treatment failure in patients with minimally differentiated acute myeloid leukaemia (AML-M0). Blood 83:1619-1625
39. Suciu S, Kuse R, Weh HJ, Hossfeld DK (1990) Results of chromosome studies and their relation to morphology, course and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genet Cytogenet 44:15-26
40. Tabernero MD, Ríos A, San Miguel JF, Orfao A (1993) Hibridación in situ (HIS) por métodos no-radiactivos para la detección de alteraciones numéricas de cromosomas. Patología 26:103-111
41. Tabernero MD, San Miguel JF, García JL, García-Isidoro M, Wiegant J, Ciudad J, González M. Ríos A, Raap AK, Orfao A (1995) Clinical, biological and immunophenotypical characteristics of B-cell chronic lymphocytic leukaemia with trisomy 12 by fluorescence in situ hybridisation. Cytometry 22:217-222
42. Tabernero MD, San Miguel JF, García-Sanz R, Nájera ML, García-Isidoro M. Pérez-Simón JA, González M, Wiegant J, Raap AK, Orfao A (1996) Incidence of chromosome numerical changes in multiple myeloma. A FISH analysis using 15 chromosome-specific probes. Am J Pathol 149:153-161
43. Third MIC Cooperative Study Group (1988) Recommendations for morphologic immunologic and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Report of a workshop held in Scottsdale, Arizona, USA, on February 23-25. Cancer Genet Cytogenet 32:1-10
44. Venditti A, Poeta GD, Stasi R, Masi M, Bruno A, Buccisano F, Cox C, Coppetelli U, Aronica G, Simone DM, Tribalto M, Amadori S (1994) Minimally differentiated acute myeloid leukaemia (AML-M0): cytochemical, immunophenotypic and cytogenetic analysis of 19 cases. Br J Haematol 88:784-794
45. Vindelov LL, Christensen IBJ, Jensen G, Nissen NI (1983) Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis: results obtained by a set of methods for sample storage, staining and internal standardisation. Cytometry 3:332-338
46. Wiegant J, Ried T, Nederlof PM, Van der Ploeg M, Tanke HJ, Raap A (1991) In situ hybridisation with fluoresceinated DNA. Nucleic Acids Res 19:3237-3241
47. Yunis JJ, Lobell M, Arnesen MA, Oken MM, Mayer MG, Rydell RE, Brunning RD (1988) Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol 68:189-194